BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rainero I, Rubino E, Paemeleire K, Gai A, Vacca A, De Martino P, Gentile S, Sarchielli P, Pinessi L. Genes and primary headaches: discovering new potential therapeutic targets. J Headache Pain 2013;14:61. [PMID: 23848401 DOI: 10.1186/1129-2377-14-61] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Bentivegna E, Luciani M, Paragliola V, Baldari F, Lamberti PA, Conforti G, Spuntarelli V, Martelletti P. Recent advancements in tension-type headache: a narrative review. Expert Rev Neurother 2021;21:793-803. [PMID: 34128449 DOI: 10.1080/14737175.2021.1943363] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kondratiev AV, Shnayder NA, Shulmin A, Dmitrenko DV, Trefilova VV, Zobova SN, Kantimirova EA, Petrova MM, Kaskaeva DS, Vaiman EE, Nasyrova RF. Genetic aspects of primary headaches in Siberia (Russia). jour 2021;1:54-63. [DOI: 10.52667/2712-9179-2021-1-1-54-63] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Forster J, Duis J, Butler MG. Pharmacodynamic Gene Testing in Prader-Willi Syndrome. Front Genet 2020;11:579609. [PMID: 33329716 DOI: 10.3389/fgene.2020.579609] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Liampas IN, Siokas V, Aloizou AM, Tsouris Z, Dastamani M, Aslanidou P, Brotis A, Dardiotis E. Pyridoxine, folate and cobalamin for migraine: A systematic review. Acta Neurol Scand 2020;142:108-20. [PMID: 32279306 DOI: 10.1111/ane.13251] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
5 Rainero I, Vacca A, Govone F, Gai A, Pinessi L, Rubino E. Migraine: Genetic Variants and Clinical Phenotypes. CMC 2019;26:6207-21. [DOI: 10.2174/0929867325666180719120215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
6 Eising E, Pelzer N, Vijfhuizen LS, Vries B, Ferrari MD, 't Hoen PA, Terwindt GM, van den Maagdenberg AM. Identifying a gene expression signature of cluster headache in blood. Sci Rep 2017;7:40218. [PMID: 28074859 DOI: 10.1038/srep40218] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
7 Menon S, Nasir B, Avgan N, Ghassabian S, Oliver C, Lea R, Smith M, Griffiths L. The effect of 1 mg folic acid supplementation on clinical outcomes in female migraine with aura patients. J Headache Pain 2016;17:60. [PMID: 27339806 DOI: 10.1186/s10194-016-0652-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
8 Birru EM, Abay Z, Abdelwuhab M, Basazn A, Sirak B, Teni FS. Management of headache and associated factors among undergraduate medicine and health science students of University of Gondar, North West Ethiopia. J Headache Pain 2016;17:56. [PMID: 27216280 DOI: 10.1186/s10194-016-0647-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
9 Farooqui T. Trace Amines and Their Potential Role in Primary Headaches. Trace Amines and Neurological Disorders 2016. [DOI: 10.1016/b978-0-12-803603-7.00024-0] [Reference Citation Analysis]
10 Tóth BI, Nilius B. Transient Receptor Potential Dysfunctions in Hereditary Diseases. TRP Channels as Therapeutic Targets 2015. [DOI: 10.1016/b978-0-12-420024-1.00002-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
11 Sabato D, Lionetto L, Martelletti P. The therapeutic potential of novel anti-migraine acute therapies. Expert Opin Investig Drugs 2015;24:141-4. [PMID: 25391253 DOI: 10.1517/13543784.2015.983223] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
12 Li X, Zhou X, Peng Y, Liu B, Zhang R, Hu J, Yu J, Jia C, Sun C. Network based integrated analysis of phenotype-genotype data for prioritization of candidate symptom genes. Biomed Res Int 2014;2014:435853. [PMID: 24991551 DOI: 10.1155/2014/435853] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
13 Nilius B, Szallasi A, Sibley DR. Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine. Pharmacol Rev 2014;66:676-814. [DOI: 10.1124/pr.113.008268] [Cited by in Crossref: 338] [Cited by in F6Publishing: 348] [Article Influence: 37.6] [Reference Citation Analysis]